NantKwest competitors

NantKwest's competitors include Aeglea Biotherapeutics, Heat Biologics, ImmunoGen and Oncologie
Add company...
NantKwest
NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases.
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
ImmunoGen
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Oncologie
Oncologie is a biopharmaceutical company.
Founding Date
Founding Date
2014
Founding Date
2013
Founding Date
2008
Founding Date
1981
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Austin, US HQ
Locations
Durham, US HQ
Locations
Waltham, US HQ
Brentwood, US
Norwood, US
Locations
Boston, US HQ
Shanghai, CN
Employees
Employees
11827% increase
Employees
4518% increase
Employees
19
Employees
308
Employees
4
Valuation ($)
Valuation ($)
253.8 m
Valuation ($)
227.3 m
Valuation ($)
43.7 m
Valuation ($)
1.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
295
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
430
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$45k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$115.4m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($96.4m) (FY, 2017)
Net income
($27.2m) (FY, 2017)
Net income
($12.4m) (FY, 2017)
Net income
($96m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 26m
Total funding raised
$ 16.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Aeglea Biotherapeutics
HQ
Austin, US
Employees
45↑ 18% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company
ImmunoGen
HQ
Waltham, US
Employees
308

ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.

View company
Oncologie
HQ
Boston, US
Employees
4

Oncologie is a biopharmaceutical company.

View company